Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Skriver

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Epidemiology|November 27, 2013
Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010Christina G Jespersen, Mette Nørgaard, Søren Friis, et al.
International Journal of Cancer|September 25, 2018
Use of vitamin K antagonists and risk of prostate cancer: Meta-analysis and nationwide case-control studyKasper Bruun Kristensen, Patricia Hjorslev Jensen, Charlotte Skriver, et al.
Journal of the National Cancer Institute|November 15, 2023
Long-term aspirin use and cancer risk: a 20-year cohort studyCharlotte Skriver, Thomas Maltesen, Christian Dehlendorff, et al.
Diabetologia|August 2, 2023
Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort studyCharlotte Skriver, Søren Friis, Lotte B Knudsen, et al.
Acta Oncologica (Stockholm, Sweden)|June 6, 2022
Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosisAnne Katrine Duun-Henriksen, Christian Dehlendorff, Martin Andreas Røder, et al.
Cancer Causes & Control : CCC|August 10, 2016
Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide studyCharlotte Skriver, Christian Dehlendorff, Michael Borre, et al.
Cancer Causes & Control : CCC|January 10, 2022
Prescription rates for commonly used drugs before and after a prostate cancer diagnosisSigne Benzon Larsen, Christian Dehlendorff, Charlotte Skriver, et al.
Cancer Causes & Control : CCC|December 12, 2019
Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health StudyCharlotte Skriver, Christian Dehlendorff, Michael Borre, et al.
Annals of Internal Medicine|March 5, 2019
Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort StudyCharlotte Skriver, Christian Dehlendorff, Michael Borre, et al.
British Journal of Cancer|March 8, 2025
Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort studyCharlotte Skriver, Deirdre Cronin-Fenton, Signe Borgquist, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Epidemiology|November 27, 2013
Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010Christina G Jespersen, Mette Nørgaard, Søren Friis, et al.
International Journal of Cancer|September 25, 2018
Use of vitamin K antagonists and risk of prostate cancer: Meta-analysis and nationwide case-control studyKasper Bruun Kristensen, Patricia Hjorslev Jensen, Charlotte Skriver, et al.
Journal of the National Cancer Institute|November 15, 2023
Long-term aspirin use and cancer risk: a 20-year cohort studyCharlotte Skriver, Thomas Maltesen, Christian Dehlendorff, et al.
Diabetologia|August 2, 2023
Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort studyCharlotte Skriver, Søren Friis, Lotte B Knudsen, et al.
Acta Oncologica (Stockholm, Sweden)|June 6, 2022
Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosisAnne Katrine Duun-Henriksen, Christian Dehlendorff, Martin Andreas Røder, et al.
Cancer Causes & Control : CCC|August 10, 2016
Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide studyCharlotte Skriver, Christian Dehlendorff, Michael Borre, et al.
Cancer Causes & Control : CCC|January 10, 2022
Prescription rates for commonly used drugs before and after a prostate cancer diagnosisSigne Benzon Larsen, Christian Dehlendorff, Charlotte Skriver, et al.
Cancer Causes & Control : CCC|December 12, 2019
Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health StudyCharlotte Skriver, Christian Dehlendorff, Michael Borre, et al.
Annals of Internal Medicine|March 5, 2019
Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort StudyCharlotte Skriver, Christian Dehlendorff, Michael Borre, et al.
British Journal of Cancer|March 8, 2025
Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort studyCharlotte Skriver, Deirdre Cronin-Fenton, Signe Borgquist, et al.
Pageof 2